MedPath

LEVOTHYROXINE SODIUM FOR INJECTION

LEVOTHYROXINE SODIUM FOR INJECTION

Approved
DIN Number

02461714

Drug Class

Human

Market Date

Nov 15, 2019

Company
HC

avir pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02461714
AIG Number0107794003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
H03AA01 LEVOTHYROXINE SODIUM
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntramuscular ,  Intravenous
AHFS Classification68:36.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

LEVOTHYROXINE SODIUMActive
Strength: 200 MCG / VIAL
Monograph: LEVOTHYROXINE SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.